Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

Clinical trial finds Medihoney wipes out MRSA from chronic venous ulcers

Derma Sciences : 18 June, 2008  (Company News)
A large randomized controlled clinical trial has found that Derma Sciences’ Medihoney Wound and Burn Dressing with Active Leptospermum Honey significantly reduce the presence of methicillin-resistant Staphylococcus aureus (MRSA) in chronic wounds.
The finding was published in the June 2008 issue of The Journal of Wound Care.

Derma Sciences’ chief executive officer Ed Quilty commented, 'This study was presented last year at the European Wound Management Association, and we are pleased that the work has been recognised in such a well-regarded peer reviewed wound care journal serving the global market. MRSA, which is now reaching out beyond the walls of hospitals and nursing homes into the general community, claims more lives than AIDS in certain countries. Medihoney's ability to eradicate this superbug, while also helping chronic wounds to progress towards healing, makes it a truly unique product in the field of wound care. We, along with our global commercialization partner Comvita, have seen steady growth in interest and sales in the product line since its launch.'

The trial, a 108-patient randomized and controlled clinical trial, looked at venous leg ulcers that had been proven to be non-healing under standard treatment (compression therapy). In the study, half the patients had a common advanced wound care gel added to the standard treatment, and half had Comvita's Active Leptospermum (Manuka) Honey (now marketed under the brand name Medihoney )added. After four weeks, 70 percent of the Medihoney treated wounds versus only 16 percent of the hydrogel treated wounds had MRSA eradicated.

Published in June's Journal of Wound Care, the research paper ‘Bacteriological Changes in Sloughy Venous Leg Ulcers Treated with Manuka Honey or Hydrogel: an RCT’, was written by lead investigators Georgina T Gethin and Seamus Cowman, both of the Royal College of Surgeons in Ireland. They concluded that for sloughy venous ulcers, 'the efficacy of honey in eliminating MRSA in such wounds is a positive finding that may have implications for wound management and infection control.'

Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   Â© 2012 ProHealthServiceZone.com
Netgains Logo